[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-detail-563321-en":53,"doc-seo-563321-105":76},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":5,"data":54},{"doc_id":55,"user_id":56,"nickname":57,"user_avatar":58,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":60,"doc_content":61,"file_id":62,"file_url":63,"file_type":64,"file_size":65,"view_count":66,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":67,"language":68,"language_code":69,"site_id":70,"html_lang":69,"table_of_contents":71,"faqs":72,"seo_title":73,"seo_description":60,"update_tm":74,"read_time":75},563321,3985741905716,"Kyle","https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Ipsos Health Service Report 2025 - GLP-1s, mental health, and healthcare perceptions","Seventh edition of the Ipsos Health Service Report 2025, based on an Ipsos Global Advisor survey across 30 countries, tracking changes in public attitudes toward healthcare. The report highlights mental health as the top concern, with rising stress and limited perceptions that systems treat mental and physical health equally. It examines awareness and online discussion of GLP-1 drugs, especially their spread via social media and perceived future impacts on obesity. It also reviews perceived healthcare quality and the biggest system problems such as access, staffing, and costs.","IPSOS HEALTH SERVICE REPORT 2025  \nA 30-Country Ipsos Global Advisor Survey October 2025  \n© Ipsos Health Service Report 2025  \nIntroduction  \nWelcome to the seventh edition of the Ipsos Health Service Report. Since 2018 we have been tracking people’s attitudes and perceptions on their healthcare system and its biggest problems.  \nIn this issue we look at GLP-1s including awareness around the world and whether people think it will have an impact on obesity levels.  \nPeople are most likely to say they hear of GLP-1 drugs, which go by brand names like Ozempic or Mounjaro, through social media. We explore the social media conversations around GLP-1s and how the drugs, which are only available via prescription, are being used and marketed as a way for“healthy” people to keep the weight off.  \nThey are now being talked of as just another part of the weight loss toolkit. In much the same way you would go to the gym.  \nThe online narrative is not being driven by the pharma industry or traditional healthcare providers, but shaped by online voices.  \nUnderstanding perceptions, or perhaps misperceptions, around healthcare has never been more important. Health, like many aspects of society, is becoming more politicised and coupled with this the traditional sources of knowledge, such as doctors and the pharma sector, have less influence.  \nIn our Ipsos Global Trends work two-  \nthirds say they always try and find out  \ninformation on healthcare by themselves, rather than just relying on what their doctor tells them.  \nNowhere within health is this politicisation more apparent than in vaccines. Misinformation around vaccinations is being spread by some of the most influential voices around the world. We see falling support in many countries for compulsory vaccines for infectious diseases.  \nWe hope you find this report useful. If you have any questions about what’s covered here for your country, category or industry, please get in touch.  \nJamie Stinson, Content Director, Ipsos  \n[Jamie.Stinson@Ipsos.com](Jamie.Stinson@Ipsos.com)  \n© Ipsos Health Service Report 2025  \nAt a glance  \n45%  \non average across 30 countries say mental health is the biggest health concern. This is up from 27% in 2018. Cancer, stress, obesity, and drug abuse follow as concerns.  \n43%  \nrate the quality of healthcare they receive as good. This ranges from 75% in Malaysia feeling their healthcare is good, to only 12% in Hungary.  \n© Ipsos Health Service Report 2025  \nacross 30 countries have heard of GLP-1 drugs, such as Ozempic, Wegovy, Zepbound, Rybelsus or Mounjaro. Awareness is highest in the US (74%) .  \n28%   \non average think the quality of their healthcare will improve over the coming years, down from 34% in 2018. Twenty-one per cent think the quality will get worse.  \nPerceived biggest healthcare problems:  \nAccess to treatment/waiting times  \n47%  \nNot enough staff  \n43%  \nCost of accessing treatment  \n33%  \nAgeing population  \n23%  \nBureaucracy  \n23%  \nSummary  \nPeople much more likely to think the level of care they get is good vs. bad  \nFour in ten (43%) rate the quality of the healthcare they have access to in their country as good. Only 22% rate the care they receive as poor.  \nMalaysia and the Netherlands are the most likely to feel their healthcare system is good. Britain and Canada have experienced marked falls in their ratings in recent years.  \nWhile many European countries are more likely to rate their healthcare as good rather than poor, many think it will get worse in the future.  \nOne in two (51%) in France, 39% in Germany and 35% in the Netherlands expect quality togo down in the coming years.  \n© Ipsos Health Service Report 2025  \nMental health is seen as the top health problem  \n45% on average across 30 countries see mental health as a problem in their nation. It ranks ahead of cancer (41%) and obesity (25%) as the biggest health problems. Perception of mental health as an issue rose rapidly during the pandemic and the proportion that see ","cbCaiiLRHYzgqEK5","https://ap.wps.com/l/cbCaiiLRHYzgqEK5","pdf",3496344,7,95,"English","en",105,"# Introduction\n# At a glance\n# Summary\n# Mental health is seen as the top health problem\n# Low awareness of GLP-1s globally, but high in the most advanced economies\n# Part One: Healthcare in 2025\n## Obesity and GLP-1s\n## From medical to lifestyle","[{\"question\":\"What are the biggest healthcare concerns reported across the 30 countries?\",\"answer\":\"Mental health is cited as the biggest health concern on average (45%), followed by cancer (41%) and obesity (25%).\"},{\"question\":\"How does public perception of healthcare quality change in different countries?\",\"answer\":\"Four in ten (43%) rate the quality of healthcare as good, with notable variation, such as 75% in Malaysia versus 12% in Hungary. The report also notes marked falls in ratings in Britain and Canada.\"},{\"question\":\"How aware are people of GLP-1 drugs, and where do they hear about them?\",\"answer\":\"Across 30 countries, 36% have heard of GLP-1 drugs, rising to 74% in the US. Among those aware, 45% say they heard via social media, compared with 19% from a medical professional.\"}]","Ipsos Health Service Report 2025 - GLP-1s, mental health, and healthcare perceptions | PDF",1791828922,33,{"code":4,"msg":77,"data":78},"ok",{"site_id":70,"language":69,"slug":79,"title":59,"keywords":80,"description":60,"schema_data":81,"social_meta":137,"head_meta":139,"extra_data":141,"updated_unix":142},"ipsos-health-service-report-2025-glp-1s-mental-health-and-healthcare-perceptions","",{"@graph":82,"@context":136},[83,99,119],{"@type":84,"itemListElement":85},"BreadcrumbList",[86,90,93,96],{"item":87,"name":88,"@type":89,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":91,"name":10,"@type":89,"position":92},"https://docshare.wps.com/template/",2,{"item":94,"name":51,"@type":89,"position":95},"https://docshare.wps.com/template/general/",3,{"item":97,"name":59,"@type":89,"position":98},"https://docshare.wps.com/template/ipsos-health-service-report-2025-glp-1s-mental-health-and-healthcare-perceptions/563321/",4,{"url":97,"name":59,"@type":100,"image":101,"author":106,"headline":59,"publisher":108,"fileFormat":111,"inLanguage":69,"description":60,"dateModified":112,"datePublished":113,"encodingFormat":111,"isAccessibleForFree":114,"interactionStatistic":115},"DigitalDocument",{"url":102,"@type":103,"width":104,"height":105},"https://docshare.wps.com/thumbnails/ipsos-health-service-report-2025-glp-1s-mental-health-and-healthcare-perceptions/563321.png","ImageObject",442,249,{"name":57,"@type":107},"Person",{"url":87,"name":109,"@type":110},"DocShare","Organization","application/pdf","2026-10-30","2026-10-12",true,{"@type":116,"interactionType":117,"userInteractionCount":66},"InteractionCounter",{"@type":118},"ViewAction",{"@type":120,"mainEntity":121},"FAQPage",[122,128,132],{"name":123,"@type":124,"acceptedAnswer":125},"What are the biggest healthcare concerns reported across the 30 countries?","Question",{"text":126,"@type":127},"Mental health is cited as the biggest health concern on average (45%), followed by cancer (41%) and obesity (25%).","Answer",{"name":129,"@type":124,"acceptedAnswer":130},"How does public perception of healthcare quality change in different countries?",{"text":131,"@type":127},"Four in ten (43%) rate the quality of healthcare as good, with notable variation, such as 75% in Malaysia versus 12% in Hungary. The report also notes marked falls in ratings in Britain and Canada.",{"name":133,"@type":124,"acceptedAnswer":134},"How aware are people of GLP-1 drugs, and where do they hear about them?",{"text":135,"@type":127},"Across 30 countries, 36% have heard of GLP-1 drugs, rising to 74% in the US. Among those aware, 45% say they heard via social media, compared with 19% from a medical professional.","https://schema.org",{"og:url":97,"og:type":138,"og:title":59,"og:site_name":109,"og:description":60},"article",{"robots":140,"canonical":97},"index,follow",{"doc_id":55,"site_id":70},1792113470]